Group Psychotherapy of Dysfunctional Fear of Progression in Patients with Chronic Arthritis or Cancer
The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Background: This study investigated the effectiveness of brief psychotherapeutic group interventions in reducing dysfunctional fear of disease progression (FoP). The interventions comprised either cognitive-behavioral group therapy or supportive-experiential group therapy. We tested whether these generic interventions would prove effective in different illness types. Methods: Chronic arthritis in- patients (n = 174) and cancer in-patients (n = 174), respectively, were randomized to receive one of the two interventions. The patients provided data before intervention, at discharge, and at 3 and 12 months of follow-up. FoP was the primary outcome, secondary outcomes were anxiety, depression and quality of life. A treatment-as-usual control group provided data on the primary outcome. Results: Patients with chronic arthritis indicated higher levels of FoP than cancer patients. The results revealed that, compared with no specialized intervention, both group therapies were effective in reducing dysfunctional FoP, but only among cancer patients. The effect sizes were 0.54 (cognitive-behavioral therapy) and 0.50 (supportive experiential therapy). The interventions were not differently effective in reducing the secondary outcomes. Conclusions: Dysfunctional FoP can be effectively targeted with brief group interventions. Psychotherapeutic interventions for reducing FoP should focus on specific illness characteristics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Among limited studies, most of them focused on Cognitive Behavioral Therapy (CBT)'s efficacy, showing low to moderate effectsizes.[9][10][11]”
From A randomized clinical trial: Efficacy of group-based acceptance and commitment therapy program for breast cancer patients with high fear of progression (2024) · cites this paper as [9]
In the citing paper
“ConquerFear participants had clinically and statistically greater improvements than control participants from baseline to immediately post-intervention on Fear of Cancer Inventory (FCRI) scores (P < .001)and most secondary outcomes; differences on FCRI scores were maintained at 3-and 6-months follow-up.”
From Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy (2019) · cites this paper as [5]
In the citing paper
“randomized trials have shown that they significantly reduce fear of cancer recurrence relative to usual care [33], relaxation training [34], and supportive-expressive group therapy [29, 31].”
In the citing paper
“The few prior anxiety-related interventions have focused on fear of recurrence [29–31] or uncertainty in later survivorship phases [32].”
Citations
Cites
Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis
Barth, J., Schumacher, M., & Herrmann-Lingen, C. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146332.53619.b2 · Cited by 1,358 · cited 1×
“Research has shown that many medical patients suffer from comorbid mental illness [”
BackgroundSF-36, Fragebogen zum Gesundheitszustand
Bullinger, M., & Kirchberger, I. (1998) · Cited by 835
Alonso, J., Ferrer, M., Gandek, B., Ware, J. E., Aaronson, N. K., Mosconi, P., Rasmussen, N. K., Bullinger, M., Fukuhara, S., Kaasa, S., et al. (2004) · Quality of Life Research · doi:10.1023/b:qure.0000018472.46236.05 · Cited by 786 · cited 1×
“Although there are also differences in consequences [”
BackgroundWhich chronic conditions are associated with better or poorer quality of life?
Sprangers, M. A. G., de Regt, E. B., Andries, F., van Agt, H. M. E., Bijl, R. V., de Boer, J. B., Foets, M., Hoeymans, N., Jacobs, A. E., Kempen, G. I. J. M., et al. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00204-3 · Cited by 642
Newell, S. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.558 · Cited by 591
Saarni, S. I., Härkänen, T., Sintonen, H., Suvisaari, J., Koskinen, S., Aromaa, A., & Lönnqvist, J. (2006) · Quality of Life Research · doi:10.1007/s11136-006-0020-1 · Cited by 412
Mehnert, A., & Koch, U. (2007) · Psycho-Oncology · doi:10.1002/pon.1057 · Cited by 402
Kissane, D. W., Grabsch, B., Clarke, D. M., Smith, G. C., Love, A. W., Bloch, S., Snyder, R. D., & Li, Y. (2007) · Psycho-Oncology · doi:10.1002/pon.1185 · Cited by 376
Nezu, A. M., Nezu, C. M., Felgoise, S. H., McClure, K. S., & Houts, P. S. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.6.1036 · Cited by 323
Henrich, G., & Herschbach, P. (2000) · European Journal of Psychological Assessment · doi:10.1027//1015-5759.16.3.150 · Cited by 321 · cited 1×
“Two components, physical and mental, are computed with scores ranging from 0 (worst) to 100 (best). The patients reported on their HRQoL during the past 2 weeks.Life satisfaction was measured with the Questions on Life Satisfaction (FLZ M ) [”
MethodSelf-citation
Research works printed but not linked: 3
- 10.1002%2F%28SICI%291099-1611%28199706%296%3A2%3C95%3A%3AAID-PON250%3E3.0.CO%3B2-B · doi:10.1002/(sici)1099-1611(199706)6:2<95::aid-pon250>3.0.co;2-b
- 10.1111%2Fj.1440-1614.2006.01795.x · DOI
- 10.1002%2F%28SICI%291099-1611%28199703%296%3A1%3C25%3A%3AAID-PON240%3E3.3.CO%3B2-E · doi:10.1002/(sici)1099-1611(199703)6:1<25::aid-pon240>3.3.co;2-e
Cited by
Items 101–161 of 161
Peur de la récidive et/ou progression du cancer et prévention en santé mentale
Suchocka, A., & Bungener, C. (2010) · Psycho-Oncologie · doi:10.1007/s11839-010-0283-1 · Cited by 14
Self-Perceived Pain in Chinese Patients With Cancer
Zhang, Y., Tan, X., Li, W., Wang, H., Sun, H., Liu, T., Zhang, J., Zhang, B., & Yang, Y. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.01994 · Cited by 7
Yu, C.-C., Chu, C., Lai, Y., Hung, C., Chan, J., Chen, Y.-J., Hsu, H., & Lee, Y. (2022) · Cancer Nursing · doi:10.1097/ncc.0000000000001147 · Cited by 8
Yeom, C., Ha, H., Hahm, B., Lee, S. H., Kim, N. J., & Shim, E. (2024) · Journal of Health Psychology · doi:10.1177/13591053231224177 · Cited by 7
“For example, brief group interventions for dysfunctional FoP in patients with chronic arthritis and cancer significantly reduced FoP (Herschbach et al., 2010).”
Zhang, F., Liang, C., Zhang, C., Xu, K., Chen, Q., Xu, H., & Zhang, H. (2024) · BMC Psychology · doi:10.1186/s40359-024-02059-z · Cited by 7
A cross-sectional study on fear of progression in patients with myasthenia gravis
Luo, S., Xiong, Y., Song, Z., Lian, J., Qiu, Y., Zhu, M., Li, M.-H., Zhou, M., & Hong, D. (2025) · Scientific Reports · doi:10.1038/s41598-025-11806-0 · Cited by 6
“Total scores ranged from 12 to 60, with higher scores indicating greater levels of fear, with a cut-off of 34 or above indicating a dysfunctional level of fear of progression 18 .”
Follow-up in Early Breast Cancer — A Surgical and Radiological Perceptive
Dunn, J., Donnelly, P. K., Marshall, A., Wilcox, M., Watson, E. K., Young, A., Balmer, C. E., Ramírez, M. T., Hartup, S. M., Maxwell, A., et al. (2014) · Clinical Oncology · doi:10.1016/j.clon.2014.06.015 · Cited by 4
Herschbach, P., & Henningsen, P. (2010) · Springer eBooks · doi:10.1007/978-3-642-03808-2_33 · Cited by 4
Self-citationYu, Y., Feng, Y., Han, Y., Yang, J., Wen, X., Fan, X., & Fan, J. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07229-w · Cited by 6
“A cut-off of ≥ 34 to differentiate functional from dysfunctional levels of FoP was suggested by Herschbach et al. [35], which has also been used in an previous study on FoP in parents of childhood cancer patients [32].”
Herrmann, J., Herzog, K., Martini, J., Santel, A., Kulisch, L. K., Kühl, J., & Schepper, F. (2026) · Psycho-Oncology · doi:10.1002/pon.70514 · Cited by 3
“For parents we used the suggested cut‐off ≥ 34 for dysfunctional FoP [10, 15] and also applied the described the threshold based on scale level.”
Chen, J., Sun, Y., Shao, Y., Meng, A., Bai, Y., Li, X., Zhou, Z., Wang, H., & Zhi, X. (2024) · Precision Medical Sciences · doi:10.1002/prm2.12131 · Cited by 6
Cheng, Y., Liu, A., Dai, J. C., Zhuo, Y., Liu, P., Wu, Q., Li, Z., & Yang, Q. (2025) · Stress and Health · doi:10.1002/smi.70052 · Cited by 4
Möhwald, L. M., Maier, A., Grehl, T., Weyen, U., Weydt, P., Günther, R., Lingor, P., Göricke, B., Petri, S., Großkreutz, J., et al. (2025) · Neurological Research and Practice · doi:10.1186/s42466-024-00363-y · Cited by 4
Momeni, N. S., Aghayousefi, A., Khoshli, A. K., & Rostamian, A. (2020) · Qom Univ Med Sci J · doi:10.29252/qums.14.8.39 · Cited by 3
Li, J., Zhu, S., & Gao, W. (2022) · European Journal of Cancer Care · doi:10.1111/ecc.13762 · Cited by 2
Fear of disease progression in patients after open-heart surgery: A cross-sectional study.
Liang, Z., Lin, S., Sun, H., Liao, Y., Chen, C., Zhang, M., & Song, H. (2025) · Heart & Lung · doi:10.1016/j.hrtlng.2025.05.018 · Cited by 3
Fear of progression in Parkinson's disease: Role of age and occupational status
D’Souza, S., Tekampe, E., Falkenburger, B. H., & Schnalke, N. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251365243 · Cited by 2
“11 Unfortunately, the supply of psychological counselling does not match the demand: Half of PwPD in our study indicated a need for psychological counselling.”
Gedamu, S., Dires, A., Goshiye, D., Girma, M., Zeleke, M., Haile, D. H., Nigat, A. B., & Amare, A. T. (2025) · Scientific Reports · doi:10.1038/s41598-025-28868-9 · Cited by 3
“Elevated fear of progression becomes dysfunctional, affecting wellbeing, quality of life, and social functioning are in need for treatment 4–6 .”
Psychosocial burden in adrenocortical carcinoma patients
Kimpel, O., Kiermeier, S., Stahl, E., Altieri, B., Faßnacht, M., & Maatouk, I. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf259 · Cited by 2
Zimmermann, T. (2011) · Verhaltenstherapie · doi:10.1159/000330465 · Cited by 2
“Hier könnte eine höherfrequente Intervention, die stärker auf die Bewältigung von Angst und psychischer Belastung bei Krebs zugeschnitten ist, hilfreicher sein [Herschbach et al., 2010].”
BackgroundGiesler, J. M., & Weis, J. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08800-z · Cited by 5
“…the sample’s HRQoL, depression, and FoP to reference values of the general population [30, 31] and to a recommended cut-off for dysfunctional FoP [32] The study was part of a larger research project focusing upon the measurement of patient competencies in the context of cancer, their potential…”
BackgroundMethodInfluentialPsychosomatic Approach to Clinical Practice
Tossani, E., & Fava, G. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7119-6_7 · Cited by 2
Motherhood and Well-Being in Young Breast Cancer Survivors
Arès, I. (2013) · uO Research (University of Ottawa) · doi:10.20381/ruor-3390 · Cited by 4
Maheu, C., Lebel, S., Courbasson, C. M. A., Lefèbvre, M., Singh, M. D., Bernstein, L. J., Muraca, L., Benea, A., Jolicoeur, L. J. A., Harris, C., et al. (2021) · doi:10.32920/14639010 · Cited by 2
Maheu, C., Lebel, S., Courbasson, C. M. A., Lefèbvre, M., Singh, M. D., Bernstein, L. J., Muraca, L., Benea, A., Jolicoeur, L. J. A., Harris, C., et al. (2021) · doi:10.32920/14639010.v1 · Cited by 2
Qiu, R., Li, Y., Pan, Y., Ye, L., Ren, C., Zhou, Q., & Sun, J. (2025) · BMC Nursing · doi:10.1186/s12912-025-04035-3 · Cited by 1
“A score of ≥ 34 is considered a borderline threshold indicative of mental dysfunction related to FoP [26].”
Ma, J., Xu, H., Yang, B., Han, X., Chen, Q., He, X., & Qiao, C.-P. (2025) · World Journal of Psychiatry · doi:10.5498/wjp.v15.i12.112651 · Cited by 3
Kiermeier, S., Schott, S., Nees, J., Dutzmann, C. M., Silchmüller, F., Kratz, C. P., Keymling, M., & Maatouk, I. (2025) · Journal of Genetic Counseling · doi:10.1002/jgc4.70148 · Cited by 3
“Fear of progression (FoP) refers to the fear of cancer developing, recurring, or progressing in cancer patients or survivors and represents a significant concern in psycho-oncological care (Herschbach et al., 2010).”
Gao, Y.-M., Lin, X.-H., Shen, X.-N., Zhao, X.-Y., Zhao, D., & Li, P. (2026) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2025.112516 · Cited by 1
Interventions to Reduce Fear of Cancer Recurrence Among People With Cancer: Scoping Review
Li, N., Wensley, C. J., Reynolds, L., Baraza, W., Leyton, T. O., & Jull, A. (2026) · JMIR Cancer · doi:10.2196/81579 · Cited by 2
“%) were delivered face to face by disciplinary specialists [36,39,45,83,95,96, 105,152,154,155,157], while 7 (30.4”
InfluentialMa, G., Jiao, P., Zeng, X., Ding, Q., Huang, Z., Gu, C., & Xie, J. (2026) · Asia-Pacific Journal of Oncology Nursing · doi:10.1016/j.apjon.2026.100926 · Cited by 1
“21 In the present study, Cronbach's alpha coefficient was 0.924, indicating good internal consistency.”
InfluentialDeath anxiety predicts fear of progression in people with rheumatic conditions
Richmond, B., Sharpe, L., Boyse, J. B., Shaw, J., & Menzies, R. E. (2026) · British Journal of Health Psychology · doi:10.1111/bjhp.70069 · Cited by 1
“…Cognitive Behaviour Therapy (CBT) for FoP with an active control in samples with either cancer or arthritis, Herschbach and colleagues (Herschbach et al., 2009) found CBT to be more efficacious than the control treatment for individuals with cancer but not for those with arthritis.”
Biermann, J., Paul, V., Bergelt, C., Inhestern, L., & Kuhlen, M. (2026) · JMIR Research Protocols · doi:10.2196/91737
Panik-, Angst- und Zwangsstörungen
Härtling, S., & Hoyer, J. (2017) · Springer eBooks · doi:10.1007/978-3-662-54644-4_18 · Cited by 1
Advances in Research on Fear of Disease Progression in Patients with Cardiovascular Disease
蒯, 颖. (2024) · Nursing Science · doi:10.12677/ns.2024.135094 · Cited by 1
Zhang, J., Zhuang, J., Chen, X., Chu, T., Zhang, Q., Ma, L., Zhou, H., Wu, Y., & Chen, L. (2025) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s534595 · Cited by 2
Tomei, C. (2017) · uO Research (University of Ottawa) · doi:10.20381/ruor-20486
Shared decision-making in rheumatology : what matters to patients?
Nota, I. (2017) · doi:10.3990/1.9789036543897 · Cited by 2
Yu, C. C., Chu, C., Lai, Y. H., Chan, J., Chen, Y. J., Hsu, H., & Lee, Y. (2021) · Research Square · doi:10.21203/rs.3.rs-545027/v1
Factors affecting fear of breast cancer recurrence in a developing country
Ibrahim, N. Y., Talima, S. M., & Darwish, D. (2021) · The Annals of Clinical and Analytical Medicine · doi:10.4328/acam.20320
“A score of 34 or above indicates a dysfunctional level of FoP-Q-12 (Herschbach et al., 2010; Hinz et al., 2015) [14,15].”
BackgroundInfluentialAngstkonfrontation bei Progredienzangst
Berg, P., & Dinkel, A. (2023) · Psychotherapie im Alter · doi:10.30820/1613-2637-2023-1-45
Self-citationVoineskos, S. H., Gallo, L., Kaur, M. N., Tsangaris, E., Griffith, L. E., Nelson, J. A., Klassen, A. F., & Pusic, A. L. (2023) · Plastic Surgery · doi:10.1177/22925503231161067
Tutus, D., Niemitz, M., Plener, P. L., Fegert, J. M., Lehmann, C., Weiss, C., Knaevelsrud, C., Biehl, L., & Rassenhofer, M. (2023) · Research Square · doi:10.21203/rs.3.rs-3289390/v1
Wu, S., Niu, Y., Geng, X., Kou, C., & Lv, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-3855508/v1
Wang, T., Yuan, X., Yang, J., Li, X., Yao, Q., Ye, T., Huang, Y., Lan, J., Zhang, X., Luo, J., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4789848/v1
A common metric for questionnaires on health anxiety in cancer patients
Friedrich, M., Schulte, T., Malburg, M., & Hinz, A. (2024) · Frontiers in Psychology · doi:10.3389/fpsyg.2024.1455121
Adaptation and validation of the Health Anxiety Inventory (short version) for medical settings
Colenutt, J., & Daniels, J. (2025) · The Cognitive Behaviour Therapist · doi:10.1017/s1754470x2400045x · Cited by 3
“However, some argue elevated anxiety is a realistic and proportionate response to the presence of severe or life-threatening physical symptoms (Herschbach et al ., 2010; Melchior et al ., 2013; Mehnert et al ., 2009).”
(2025) · Elsevier eBooks · doi:10.1016/b978-3-437-21835-4.00116-5
Xu, L., Li, C., & Lifeng, Y. (2025) · Research Square · doi:10.21203/rs.3.rs-6747858/v1
Kuo, Y., Hung, Y., Peng, H., Huang, B., & Chen, S. (2025) · Supportive Care in Cancer · doi:10.1007/s00520-025-10100-z · Cited by 1
“Scores ≥ 34 indicate high levels of FoP [30].”
Wu, Y., Zhang, Y., Zhang, L., Yang, J., Zhu, W., & Xu, C. (2025) · International Journal of Women s Health · doi:10.2147/ijwh.s563088 · Cited by 1
“22 In this study, the scale demonstrated excellent reliability, with a Cronbach’s α coefficient of 0.801, confirming its validity for measuring fear of progression.”
InfluentialNees, J., Kiermeier, S., Silchmüller, F. J., Keymling, M., Kratz, C. P., Maatouk, I., & Schott, S. (2026) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-026-08308-3
“A cut off of 34 for fear of progression and that of 5 for distress were considered as indicative of needing further attention and perhaps intervention [18, 19].”
Han, L., An, Z., Shi, H., He, Y., Wang, Y., & Ruiling, L. I. (2026) · Topics in Stroke Rehabilitation · doi:10.1080/10749357.2026.2620026
Li, X., Cao, S., Guo, F., Zhang, Y., Yu, J., & Cui, L. (2026) · Seminars in Oncology Nursing · doi:10.1016/j.soncn.2026.152123
Existential concerns and fear of recurrence or progression in people with migraine
Yadav, V., & Menzies, R. E. (2026) · Journal of Health Psychology · doi:10.1177/13591053261435786
“Research on treatments for elevated illness-related fears has demonstrated that interventions such as cognitive-behavioural therapy (CBT) and supportive-expressive group therapy are effective in reducing FCR and FoP in people with cancer (Herschbach et al., 2010; Tauber et al., 2019).”
Wang, Y., Wu, C., Jheng, Y.-W., Wu, H.-C., & Lin, C. (2026) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2026.103203
Qingqing, Z., Li, J., & Gaoye, L. (2026) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2026.146014
Tian, L. D., Feng, X., Liu, M. N., Jiang, J., Qin, Q., Xie, W., Guo, Y. L., Zhao, J., Yu, L., Ma, X., et al. (2026) · BMC Cancer · doi:10.1186/s12885-026-16468-3
“Higher scores indicate greater fear of progression, with a score of 34 or above serving as the threshold for identifying individuals with statistically significant psychological dysfunction related to FoP [39].”
Boyse, J. B., Sharpe, L., Richmond, B., Dear, B. F., Dudeney, J. E., Sesel, A.-L., & Menzies, R. E. (2026) · Journal of Health Psychology · doi:10.1177/13591053261483481
Seibel, B. L. (2012) · Americanae (AECID Library)
Panik-, Angst- und Zwangsstörungen
Chaker, S., & Hoyer, J. (2012) · Springer eBooks · doi:10.1007/978-3-642-03497-8_18 · Cited by 1
Metadata
- Authors
- Herschbach, P., Berg, P., Waadt, S., Duran, G., Engst-Hastreiter, U., Henrich, G., Book, K., & Dinkel, A.
- Affiliations
- TUM Klinikum (DE)
- IFT Institut für Therapieforschung (DE)
- Schön Klinik Bad Aibling (DE)
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2009-11-04
- Volume
- 79
- Issue
- 1
- Pages
- 31-38
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- OpenAlex
- W2002637335
- Cited by
- 161
- References
- 50
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 19 · 2023: 10 · 2022: 7 · 2021: 11 · 2020: 14 · 2019: 7 · 2018: 5 · 2017: 8 · 2016: 3 · 2015: 5 · 2014: 9 · 2013: 7 · 2012: 8
- FWCI
- 7.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Funders
- Bundesministerium für Bildung und Forschung
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- fear of progression, group therapy, cognitive behavioral therapy, chronic arthritis, cancer patients, anxiety, depression, quality of life
- MeSH terms
- Anxiety Disorders, Arthritis, Rheumatoid, Chronic Disease, Depressive Disorder, Fear, Female, Follow-Up Studies, Humans, Male, Middle Aged, Neoplasms, Psychotherapy, Group, Quality of Life
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.